BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 3188577)

  • 1. Comparison of covalent binding from halothane metabolism in hepatic microsomes from phenobarbital-induced and hyperthyroid rats.
    Smith AC; Roberts SM; James RC; Berman LM; Harbison RD
    Xenobiotica; 1988 Aug; 18(8):991-1001. PubMed ID: 3188577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study on the irreversible binding of labeled halothane trichlorofluoromethane, chloroform, and carbon tetrachloride to hepatic protein and lipids in vitro and in vivo.
    Uehleke H; Werner T
    Arch Toxicol; 1975 Dec; 34(4):289-308. PubMed ID: 3152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An animal model of halothane hepatotoxicity: roles of enzyme induction and hypoxia.
    McLain GE; Sipes IG; Brown BR
    Anesthesiology; 1979 Oct; 51(4):321-6. PubMed ID: 484893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hyperthyroidism on the in vitro metabolism and covalent binding of 1,1-dichloroethylene in rat liver microsomes.
    Gunasena GH; Kanz MF
    J Toxicol Environ Health; 1997 Oct; 52(2):169-88. PubMed ID: 9310148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactivation and covalent binding of halothane to liver macromolecules.
    Sipes IG; Podolsky TL; Brown BR
    Environ Health Perspect; 1977 Dec; 21():171-8. PubMed ID: 612442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of piperonyl butoxide on halothane hepatotoxicity and metabolism in the hyperthyroid rat.
    Smith AC; Roberts SM; Berman LM; Harbison RD; James RC
    Toxicology; 1988 Jun; 50(1):95-105. PubMed ID: 3388433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Halothane hepatotoxicity in hyperthyroid rats as compared to the phenobarbital-hypoxia model.
    Siegers CP; Frühling A; Younes M
    Toxicol Appl Pharmacol; 1983 Jun; 69(2):257-64. PubMed ID: 6868087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the NADPH-dependent covalent binding of [14C]halothane to human liver microsomes: a role for cytochrome P4502E1 at low substrate concentrations.
    Madan A; Parkinson A
    Drug Metab Dispos; 1996 Dec; 24(12):1307-13. PubMed ID: 8971135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro studies on irreversible binding of halothane metabolite to microsomes.
    Van Dyke RA; Wood CL
    Drug Metab Dispos; 1975; 3(1):51-7. PubMed ID: 234835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactivation and covalent binding of halothane in vitro: studies with [3H]- and [14C]halothane.
    Gandolfi AJ; White RD; Sipes IG; Pohl LR
    J Pharmacol Exp Ther; 1980 Sep; 214(3):721-5. PubMed ID: 7400975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrahepatic tissue distribution, covalent binding, and toxicity of halothane in control and phenobarbital-pretreated rats.
    Rao GS; Grumley JO
    Pharmacol Ther Dent; 1978; 3(2-4):101-9. PubMed ID: 286368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of hyperthyroidism enhancement of halothane-induced hepatotoxicity.
    Smith AC; Berman ML; James RC; Harbison RD
    Biochem Pharmacol; 1983 Dec; 32(23):3531-9. PubMed ID: 6651874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia and halothane metabolism in vivo: release of inorganic fluoride and halothane metabolite binding to cellular constituents.
    Widger LA; Gandolfi AJ; Van Dyke RA
    Anesthesiology; 1976 Mar; 44(3):197-201. PubMed ID: 1267885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
    Ferrara R; Tolando R; King LJ; Manno M
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins.
    Juedes MJ; Bulger WH; Kupfer D
    Drug Metab Dispos; 1987; 15(6):786-93. PubMed ID: 2893703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent binding of 14C- and 35S-labeled thiocarbamides in rat hepatic microsomes.
    Decker CJ; Doerge DR
    Biochem Pharmacol; 1992 Feb; 43(4):881-8. PubMed ID: 1371686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulegone mediated hepatotoxicity: evidence for covalent binding of R(+)-[14C]pulegone to microsomal proteins in vitro.
    Madyastha KM; Moorthy B
    Chem Biol Interact; 1989; 72(3):325-33. PubMed ID: 2691105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anticonvulsant agents on halothane-induced liver injury in human subjects and experimental animals.
    Nomura F; Hatano H; Ohnishi K; Akikusa B; Okuda K
    Hepatology; 1986; 6(5):952-6. PubMed ID: 3093358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation of the serotonergic neurotoxin para-chloroamphetamine to chemically reactive intermediates by hepatic and brain microsomal preparations.
    Miller KJ; Anderholm DC; Ames MM
    Biochem Pharmacol; 1986 May; 35(10):1737-42. PubMed ID: 3707603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygen concentrations required for reductive defluorination of halothane by rat hepatic microsomes.
    Lind RC; Gandolfi AJ; Sipes IG; Brown BR; Waters SJ
    Anesth Analg; 1986 Aug; 65(8):835-9. PubMed ID: 3729018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.